A look at research suggesting drugs such as Wegovy may lower the risk of certain cancers. Tap through for which cancers and how strong the evidence is.
Recap by typeshit. Full story at www.polskieradio.pl.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
She points out one trial enrolled people with diabetes and the other excluded them, so the results aren't a head to head match.
Loading…